Clinical trial
Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer…
NCT00303758 · Federation Francophone de Cancerologie Digestive, Other · Completed
Key facts
| NCT number | NCT00303758 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery |
| Official title | Essai Randomise Comparant Deux Stategies De Chimiotherapie Dans Les Cancers Pancreatiques Avances: LV5FU2 Simplifie + Cisplatine Suivi de Gemcitabine, Versus Gemcitabine Suivi de LV5FU2 Simplifie + Cisplatine en Can de Progression |
| Lead sponsor | Federation Francophone de Cancerologie Digestive, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, fluorouracil, gemcitabine hydrochloride, leucovorin calcium |
| Enrollment | 202 |
| Start date | Oct 1, 2005 |
| Primary completion | Mar 1, 2012 |
| Completion | Mar 1, 2012 |
| First posted | Mar 17, 2006 |
| Last update posted | Mar 4, 2014 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: